✦ LIBER ✦

Efficacy of routine follow-up after first-line treatment for testicular cancer

✍ Scribed by J. R. Spermon; J. A. Witjes; L. A. L. M. Kiemeney

Publisher: Springer-Verlag
Year: 2004
Tongue: English
Weight: 233 KB
Volume: 22
Category: Article
ISSN: 0724-4983
DOI: 10.1007/s00345-004-0441-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Detection of bone metastases in routine

Detection of bone metastases in routine follow-up after treatment for primary breast cancer

✍ Nobuaki Sato; Masato Hino; Muneaki Sano 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 654 KB

Effect of routine follow-up after treatm

Effect of routine follow-up after treatment for laryngeal cancer on life expectancy and mortality : Results of a Markov model analysis

✍ Savitri C. Ritoe; Femmie de Vegt; Inger M. Scheike; Paul F. M. Krabbe; Johannes 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

## Abstract ## BACKGROUND. Routine follow‐up is offered to all patients with laryngeal cancer who are treated with curative intent. Although time and resources are devoted to surveillance, the effect of asymptomatic recurrence detection is not well understood. For this study, the authors evaluated

Economic evaluation of a randomized clin

Economic evaluation of a randomized clinical trial of hospital versus telephone follow-up after treatment for breast cancer

✍ Professor K. Beaver; W. Hollingworth; R. McDonald; G. Dunn; D. Tysver-Robinson; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views

Combination of topotecan and etoposide a

Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy

✍ Hye Jin Choi; Byoung Chul Cho; Sang Joon Shin; Seong Ha Cheon; Jong Yul Jung; Jo 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 245 KB

Randomized phase III study comparing the

Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)

✍ Hiroyuki Narahara; Hiroyasu Iishi; Hiroshi Imamura; Akira Tsuburaya; Keisho Chin 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 415 KB

## Background Irinotecan hydrochloride and S-1, an oral fluoropyrimidine, have shown antitumor activity against advanced gastric cancer as single agents in phase I/II studies. The combination of irinotecan and S-1 (IRI-S) is also active against advanced gastric cancer. This study was conducted to c